During the past decade, there have been important progresses and innovations in both basic and clinical fields of renal cell carcinoma. Major advances have been observed in the understanding of pathogenesis of renal cell carcinoma both at molecular and genetic levels. Improvements in imaging technology, including computerized scan and magnetic resonance imaging, has allowed accurate and detailed preoperative staging. Surgical management was revolutionized with the widespread use of nephron sparing surgery as well as the introduction of laparoscopic and robotic techniques. New treatment modalities were introduced to the market such as tumor ablation and active surveillance. Recently, the approval of new drugs targeting specific carcinogensis pathways had improved survival in patients with metastatic disease. Herein, we reviewed changes in our knowledge in terms of pathogenesis, surgical and medical management of renal cell carcinoma. We also revisited clinical and pathological factors that govern outcome of renal cell carcinoma.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
During the past decade, there have been important progresses and innovations in both basic and clinical fields of renal cell carcinoma. Major advances have been observed in the understanding of pathogenesis of renal cell carcinoma both at molecular and genetic levels. Improvements in imaging technology, including computerized scan and magnetic resonance imaging, has allowed accurate and detailed preoperative staging. Surgical management was revolutionized with the widespread use of nephron sparing surgery as well as the introduction of laparoscopic and robotic techniques. New treatment modalities were introduced to the market such as tumor ablation and active surveillance. Recently, the approval of new drugs targeting specific carcinogensis pathways had improved survival in patients with metastatic disease. Herein, we reviewed changes in our knowledge in terms of pathogenesis, surgical and medical management of renal cell carcinoma. We also revisited clinical and pathological factors that govern outcome of renal cell carcinoma.
I am attached to research since I have been in McGill university. My main interest of research is urologic oncology and specifically kidney cancer. Renal cell carcinoma was the topic of my thesis, and many publication came out from this work, as we pioneered the study of active surveillance, and mTOR pathway in RCC.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -During the past decade, there have been important progresses and innovations in both basic and clinical fields of renal cell carcinoma. Major advances have been observed in the understanding of pathogenesis of renal cell carcinoma both at molecular and genetic levels. Improvements in imaging technology, including computerized scan and magnetic resonance imaging, has allowed accurate and detailed preoperative staging. Surgical management was revolutionized with the widespread use of nephron sparing surgery as well as the introduction of laparoscopic and robotic techniques. New treatment modalities were introduced to the market such as tumor ablation and active surveillance. Recently, the approval of new drugs targeting specific carcinogensis pathways had improved survival in patients with metastatic disease. Herein, we reviewed changes in our knowledge in terms of pathogenesis, surgical and medical management of renal cell carcinoma. We also revisited clinical and pathological factors that govern outcome of renal cell carcinoma. 196 pp. Englisch. N° de réf. du vendeur 9783659584848
Quantité disponible : 2 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - During the past decade, there have been important progresses and innovations in both basic and clinical fields of renal cell carcinoma. Major advances have been observed in the understanding of pathogenesis of renal cell carcinoma both at molecular and genetic levels. Improvements in imaging technology, including computerized scan and magnetic resonance imaging, has allowed accurate and detailed preoperative staging. Surgical management was revolutionized with the widespread use of nephron sparing surgery as well as the introduction of laparoscopic and robotic techniques. New treatment modalities were introduced to the market such as tumor ablation and active surveillance. Recently, the approval of new drugs targeting specific carcinogensis pathways had improved survival in patients with metastatic disease. Herein, we reviewed changes in our knowledge in terms of pathogenesis, surgical and medical management of renal cell carcinoma. We also revisited clinical and pathological factors that govern outcome of renal cell carcinoma. N° de réf. du vendeur 9783659584848
Quantité disponible : 1 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Abou Youssif TamerI am attached to research since I have been in McGill university. My main interest of research is urologic oncology and specifically kidney cancer. Renal cell carcinoma was the topic of my thesis, and many publicati. N° de réf. du vendeur 5166618
Quantité disponible : Plus de 20 disponibles
Vendeur : Books Puddle, Woodside, NY, Etats-Unis
Etat : New. pp. 196. N° de réf. du vendeur 26359066814
Quantité disponible : 4 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Outcome Predictors In Patients with Renal Cell Carcinoma | Identification of clinical and pathological prognostic factor in renal cell carcinoma | Tamer Abou Youssif | Taschenbuch | 196 S. | Englisch | 2014 | LAP LAMBERT Academic Publishing | EAN 9783659584848 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu. N° de réf. du vendeur 105141779
Quantité disponible : 5 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -During the past decade, there have been important progresses and innovations in both basic and clinical fields of renal cell carcinoma. Major advances have been observed in the understanding of pathogenesis of renal cell carcinoma both at molecular and genetic levels. Improvements in imaging technology, including computerized scan and magnetic resonance imaging, has allowed accurate and detailed preoperative staging. Surgical management was revolutionized with the widespread use of nephron sparing surgery as well as the introduction of laparoscopic and robotic techniques. New treatment modalities were introduced to the market such as tumor ablation and active surveillance. Recently, the approval of new drugs targeting specific carcinogensis pathways had improved survival in patients with metastatic disease. Herein, we reviewed changes in our knowledge in terms of pathogenesis, surgical and medical management of renal cell carcinoma. We also revisited clinical and pathological factors that govern outcome of renal cell carcinoma.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 196 pp. Englisch. N° de réf. du vendeur 9783659584848
Quantité disponible : 1 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. Print on Demand pp. 196 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam. N° de réf. du vendeur 353456993
Quantité disponible : 4 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. PRINT ON DEMAND pp. 196. N° de réf. du vendeur 18359066804
Quantité disponible : 4 disponible(s)